Immediate Impact
2 from Science/Nature 70 standout
Citing Papers
Global Effect of Cardiovascular Risk Factors on Lifetime Estimates
2025 Standout
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
2024 Standout
Works of Jeffrey S. Riesmeyer being referenced
The dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes
2020
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jeffrey S. Riesmeyer | 325 | 377 | 216 | 23 | 694 | |
| Anders Bröijersén | 206 | 284 | 117 | 27 | 700 | |
| Stefano Lattanzio | 156 | 348 | 98 | 18 | 660 | |
| Elisabetta Ferrante | 220 | 483 | 127 | 19 | 771 | |
| Birgit Svensson | 200 | 169 | 110 | 28 | 616 | |
| Joerg Kreuzer | 123 | 317 | 191 | 21 | 722 | |
| P. Roesen | 148 | 379 | 143 | 18 | 695 | |
| Peter Bacher | 162 | 260 | 144 | 36 | 583 | |
| Thomas Toscano | 293 | 574 | 84 | 23 | 831 | |
| P L Mattioli | 109 | 292 | 98 | 17 | 614 | |
| Satomi Iwashita | 168 | 573 | 192 | 20 | 810 |
All Works
Login with ORCID to disown or claim papers
Loading papers...